68083-343-05 : NDC 2026 Code

68083-343-05 : Cytarabine ( Cytarabine )

Additionally :

You can get information about “68083-343-05” NDC code in 68083-343-05 in HTML format

HTML | 68083-343-05 in TXT (Plain Text) format

TXT | 68083-343-05 in PDF (Portable Document Format)

PDF | 68083-343-05 in XML format

XML formats.

NDC Code : 68083-343-05 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "68083-343-05",
    "PackageDescription": "5 VIAL, SINGLE-DOSE in 1 CARTON (68083-343-05)  &gt; 5 mL in 1 VIAL, SINGLE-DOSE (68083-343-01) ",
    "NDC11Code": "68083-0343-05",
    "ProductNDC": "68083-343",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Cytarabine",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Cytarabine",
    "DosageFormName": "INJECTION, SOLUTION",
    "RouteName": "INTRATHECAL; INTRAVENOUS; SUBCUTANEOUS",
    "StartMarketingDate": "20191223",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA211937",
    "LabelerName": "Gland Pharma Limited",
    "SubstanceName": "CYTARABINE",
    "StrengthNumber": "20",
    "StrengthUnit": "mg/mL",
    "Pharm_Classes": "Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2020-07-16",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20191223",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}